Product image of Monopost (Latanoprost) supplied by GNH India

Monopost

Active Ingredient:
Latanoprost
Origin:
EU

Monopost (Latanoprost)

Latanoprost, the active ingredient in Monopost, is a prostaglandin analog presented as eye drops for ocular (topical) use. It lowers intra‑ocular pressure and is prescribed for primary open‑angle glaucoma and ocular hypertension in adult patients to help preserve visual function. The medication works by enhancing the outflow of fluid through the uveoscleral pathway, thereby reducing pressure on the optic nerve.

GNH India supplies Monopost as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with consistent quality and regulatory compliance.

Manufacturer / TM Owner

Laboratoires Thea

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Latanoprost is used to lower intra‑ocular pressure in glaucoma‑related conditions.
  • Primary open‑angle glaucoma: reduces intra‑ocular pressure to help prevent optic nerve damage.
  • Ocular hypertension: lowers intra‑ocular pressure to reduce risk of progression to glaucoma.
  • Secondary open‑angle glaucoma: assists in pressure control when other therapies are insufficient.

How It Works

  • Latanoprost is a synthetic analogue of prostaglandin F₂α that binds to FP receptors on the ciliary muscle and scleral tissue. Activation of these receptors stimulates remodeling of the extracellular matrix, increasing uveoscleral outflow of aqueous humor. The enhanced drainage lowers intra‑ocular pressure, providing therapeutic benefit in glaucoma and ocular hypertension. This effect is sustained with once‑daily dosing and does not rely on systemic absorption.

Side Effects

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Increased eyelash growth: longer, thicker lashes.
  • Iris darkening: gradual brownish pigmentation.
  • Eye irritation: foreign‑body sensation or itching.
  • Blurred vision: transient visual disturbance.
  • Periorbital skin darkening: mild hyperpigmentation around the eye.

Serious or Rare Side Effects

  • Severe eye pain: may indicate inflammation.
  • Vision loss: sudden decrease in visual acuity.
  • Uveitis: intra‑ocular inflammation requiring medical attention.
  • Macular edema: swelling of the central retina.
  • Allergic reaction: swelling, rash, or hives.
  • Corneal ulcer: open sore on the cornea.

Precautions & Warnings

  • Before prescribing Latanoprost, clinicians should consider several safety and handling precautions.
  • Pregnancy: safety not established; use only if potential benefit justifies risk.
  • Breastfeeding: unknown excretion; caution advised.
  • Ocular surgery: postpone treatment at least four weeks before and after procedure.
  • Active ocular inflammation: avoid use until inflammation resolves.
  • Contact lens wear: discontinue lenses during treatment as drug may absorb.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid)

  • Other prostaglandin analog eye drops: combined use increases risk of ocular side effects.
  • Systemic carbonic anhydrase inhibitors: may cause excessive intra‑ocular pressure reduction.

Moderate Interactions (Monitor Closely)

  • Beta‑blocker eye drops: additive IOP‑lowering effect; monitor pressure.
  • Alpha‑agonist eye drops: potential additive hypotensive effect.
  • Systemic non‑steroidal anti‑inflammatory drugs (NSAIDs): may diminish prostaglandin activity.
  • Anticholinergic eye drops: possible alteration of ocular dynamics.

Frequently Asked Questions

Monopost contains Latanoprost, a prostaglandin analog indicated for lowering intra‑ocular pressure in patients with primary open‑angle glaucoma and ocular hypertension. By reducing pressure within the eye, it helps to prevent optic nerve damage and preserve visual function.

Latanoprost mimics prostaglandin F₂α and binds to FP receptors in the eye. This triggers remodeling of extracellular matrix proteins, which increases the uveoscleral outflow of aqueous humor. The enhanced drainage lowers intra‑ocular pressure, the primary therapeutic goal in glaucoma management.

The dosing regimen for Monopost is determined by the prescribing clinician. In clinical practice, a single drop is typically instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Safety data for Latanoprost in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, and excretion in breast milk has not been established. Use only if the potential benefit outweighs any possible risk, and discuss with a healthcare professional.

To place an order, submit an enquiry on the Monopost product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Monopost (Latanoprost) belongs to the prostaglandin analog class, which generally provides greater intra‑ocular pressure reduction with once‑daily dosing compared with beta‑blocker eye drops such as timolol. Prostaglandin analogs also have a different side‑effect profile, notably affecting iris colour and eyelash growth, while beta‑blockers may cause systemic cardiovascular effects.

Monopost eye drops should be stored at room temperature, below 25 °C, in the original container. Protect the product from light and moisture, and keep the cap tightly closed when not in use. Do not freeze the solution.

Monopost is applied topically to the eye. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place one drop into the conjunctival sac. Close the eye gently for a few seconds and avoid touching the tip of the bottle to any surface.

Serious adverse events, although rare, include severe eye pain, sudden vision loss, uveitis, macular edema, corneal ulceration, and allergic reactions such as swelling or rash. Any of these symptoms require immediate medical evaluation.

Monopost should be avoided in patients with known hypersensitivity to Latanoprost or any component of the formulation, in eyes with active intra‑ocular inflammation, and in individuals who have undergone recent ocular surgery unless cleared by the surgeon. Caution is also advised for pregnant or breastfeeding women.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT